REE Automotive (REE) CEO Daniel Barel details major option and RSU stakes
Rhea-AI Filing Summary
REE Automotive Ltd. director and CEO Daniel Barel filed an initial ownership report detailing his equity interests in the company. The Form 3 shows direct holdings of 833 Class A Ordinary Shares and 1,390,287 Class B Ordinary Shares, with each Class B share carrying 10 votes and this position representing 50% of the outstanding Class B class.
The filing also lists several option grants over Class A Ordinary Shares, with exercise prices of $1.21, $18.22 and $0.00 expiring between 2027 and 2031. In addition, Barel holds restricted stock units over 2,580,645 and 5,261,164 Class A shares under the 2021 Share Incentive Plan, including a CEO Retention Grant equal to 10% of fully diluted share capital that vests based on strategic transactions and future stock price performance.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Class A Ordinary Shares | -- | -- | -- |
| holding | Class B Ordinary Shares | -- | -- | -- |
Footnotes (1)
- The Class B Ordinary Shares each have 10 votes per share and such shares represent 50% of the outstanding Class B Ordinary Shares of the Company. Restricted Share Units ("RSUs") granted under REE Automotive Ltd.'s 2021 Share Incentive Plan ("Plan") and underlying Class A Ordinary Shares are deposited with a trustee approved by the Israeli Tax Authority for this purpose, who holds such securities in trust on behalf of the Reporting Person. Each RSU represents the right to receive, following vesting, one share of the Company's Class A Ordinary Shares. Options included here represent those with the same date of grant, January 6, 2017, that became fully exercisable on either July 1, 2018 or January 12, 2019, which have the same exercise price and expiration date. Options included here represent those with the same date of grant, November 1, 2018, that became fully exercisable on either May 1, 2021 or November 1, 2021, which have the same exercise price and expiration date. Options included here represent those with the same date of grant, November 1, 2018, that became fully exercisable on either May 1, 2021 or November 1, 2021, which have the same exercise price and expiration date. Unless earlier forfeited under the terms of the RSU, the Reporting Person receives an annual equity award in the form of RSUs with a fair value of $2,000,000 that vest quarterly in equal portions, over a three-year period. The RSUs immediately vest in the event of a change of control of the Company, which includes a Merger/Sale event as such term is defined in the Plan. On November 13, 2025, the Reporting Person was granted 2,580,645 RSUs, which vest quarterly in equal portions, over a three-year period that commenced on July 1, 2025. Unless earlier forfeited under the terms of the RSU, the Reporting Person is entitled to receive a one-time equity award in the form of RSUs equal to 10% of the Company's share capital on a fully diluted basis (the "CEO Retention Grant"). In the event the Company's fully diluted share capital increases from the level on November 13, 2025, and prior to such consummation of any such "Strategic Transaction" as defined in the Company's compensation policy, additional RSUs would be granted to the CEO to maintain the 10% ownership target at the time of such approval. In the event of a "Change of Control" transaction, which includes a Merger/Sale event, as such term is defined in the Plan, the vesting period of the CEO Retention Grant will be fully accelerated. On November 13, 2025, the Reporting Person received the CEO Retention Grant of 5,261,164 RSUs. 60% thereof vest upon the consummation of a "Strategic Transaction", as defined in the Company's compensation policy, and 40% thereof vest based on the Company's future stock price performance, as follows: i. 10% would vest upon the Company's stock achieving and maintaining a closing price of at least $2 for a period of 30 consecutive trading days, ii. 10% would vest upon the Company's stock achieving and maintaining a closing price of at least $3 for a period of 30 consecutive trading days, iii. 10% would vest upon the Company's stock achieving and maintaining a closing price of at least $4 for a period of 30 consecutive trading days and iv. 10% would vest upon the Company's stock achieving and maintaining a closing price of at least $5 for a period of 30 consecutive trading days.